{
  "dashboard": {
    "pages": [
      {
        "name": "Profitability",
        "layout": ["kpis", "charts", "insights"],
        "kpis": [
          {
            "name": "Net Income",
            "source": "profitability.net_income",
            "growth": {
              "qoq": -0.64,
              "yoy": 0.0
            }
          },
          {
            "name": "Operating Margin %",
            "calculation": 0.181
          },
          {
            "name": "Return on Equity (ROE)",
            "source": "ratios.ReturnOnEquity"
          }
        ],
        "charts": [
          {
            "type": "line",
            "metrics": ["profitability.revenue", "profitability.gross_profit"],
            "dimension": "quarter"
          },
          {
            "type": "stacked_bar",
            "metrics": ["profitability.revenue", "profitability.operating_income", "profitability.net_income"],
            "dimension": "quarter"
          },
          {
            "type": "bar_comparison",
            "metric": "ratios.ProfitMargin",
            "comparison": "sector"
          }
        ],
        "insights": "Strictly factual highlights based on revenue, income, and margins. No opinions."
      }
    ]
  },
  "companies": [
    {
      "company_info": {
        "symbol": "ABT",
        "name": "Abbott Laboratories",
        "cik": null,
        "exchange": null,
        "sector": "Healthcare",
        "industry": null,
        "fiscal_year_end": null,
        "country": null,
        "market_cap": null
      },
      "annual": {
        "profitability": {
          "revenue": 10241000000,
          "gross_profit": 5258000000,
          "operating_income": 1864000000,
          "net_income": 1594000000
        },
        "balance_sheet": {
          "cash": 6896000000,
          "assets": 73214000000,
          "liabilities": 34387000000,
          "equity": 38603000000,
          "debt": 13599000000
        },
        "cash_flow": {
          "operating_cash_flow": 3038000000,
          "capex": 755000000,
          "free_cash_flow": 2283000000,
          "earnings_quality": 1.91
        },
        "ratios": {
          "PE_Ratio": 16.53,
          "PEG_Ratio": 4.168,
          "PriceToBook": 4.535,
          "ProfitMargin": 0.324,
          "ReturnOnAssets": 0.0662,
          "ReturnOnEquity": 0.309,
          "DividendYield": 0.0179
        }
      },
      "kpis": {
        "Net Income": {
          "value": 1594000000,
          "growth": {
            "qoq": 0.0,
            "yoy": null
          }
        },
        "Operating Margin %": 0.181,
        "Return on Equity (ROE)": 0.309,
        "Free Cash Flow": {
          "value": 2283000000,
          "growth": {
            "qoq": null,
            "yoy": null
          }
        },
        "FCF Margin": 0.222
      },
      "insights": {
        "profitability": "Abbott Laboratories reported a net income of $1,594,000,000 with an operating margin of 18.1%.",
        "financial_standing": "The company has total assets of $73,214,000,000 and total liabilities of $34,387,000,000, resulting in equity of $38,603,000,000.",
        "cash_flow": "Abbott Laboratories generated a free cash flow of $2,283,000,000.",
        "ratios": "The PE ratio stands at 16.53, with a profit margin of 32.4%."
      }
    },
    {
      "company_info": {
        "symbol": "CVS",
        "name": "CVS Health Corporation",
        "cik": null,
        "exchange": null,
        "sector": "Healthcare",
        "industry": null,
        "fiscal_year_end": null,
        "country": null,
        "market_cap": null
      },
      "annual": {
        "profitability": {
          "revenue": 93813000000,
          "gross_profit": 13876000000,
          "operating_income": 3373000000,
          "net_income": 2046000000
        },
        "balance_sheet": {
          "cash": 8196000000,
          "assets": 249728000000,
          "liabilities": 173092000000,
          "equity": 76461000000,
          "debt": 58638000000
        },
        "cash_flow": {
          "operating_cash_flow": -2636000000,
          "capex": 911000000,
          "free_cash_flow": -3547000000,
          "earnings_quality": -1.29
        },
        "ratios": {
          "PE_Ratio": 19.11,
          "PEG_Ratio": 0.707,
          "PriceToBook": 1.124,
          "ProfitMargin": 0.0118,
          "ReturnOnAssets": 0.0229,
          "ReturnOnEquity": 0.0588,
          "DividendYield": 0.0399
        }
      },
      "kpis": {
        "Net Income": {
          "value": 2046000000,
          "growth": {
            "qoq": null,
            "yoy": null
          }
        },
        "Operating Margin %": 0.036,
        "Return on Equity (ROE)": 0.0588,
        "Free Cash Flow": {
          "value": -3547000000,
          "growth": {
            "qoq": null,
            "yoy": null
          }
        },
        "FCF Margin": -0.038
      },
      "insights": {
        "profitability": "CVS Health Corporation reported a net income of $2,046,000,000 with an operating margin of 3.6%.",
        "financial_standing": "The company has total assets of $249,728,000,000 and total liabilities of $173,092,000,000, resulting in equity of $76,461,000,000.",
        "cash_flow": "CVS Health Corporation reported a negative free cash flow of $3,547,000,000.",
        "ratios": "The PE ratio stands at 19.11, with a profit margin of 1.18%."
      }
    },
    {
      "company_info": {
        "symbol": "JNJ",
        "name": "Johnson & Johnson",
        "cik": null,
        "exchange": null,
        "sector": "Healthcare",
        "industry": null,
        "fiscal_year_end": null,
        "country": null,
        "market_cap": null
      },
      "annual": {
        "profitability": {
          "revenue": 21395000000,
          "gross_profit": 14597000000,
          "operating_income": 4607000000,
          "net_income": 4049000000
        },
        "balance_sheet": {
          "cash": 21859000000,
          "assets": 167558000000,
          "liabilities": 98784000000,
          "equity": 68774000000,
          "debt": 25881000000
        },
        "cash_flow": {
          "operating_cash_flow": 7863000000,
          "capex": 1589000000,
          "free_cash_flow": 6274000000,
          "earnings_quality": 1.94
        },
        "ratios": {
          "PE_Ratio": 18.91,
          "PEG_Ratio": 1.075,
          "PriceToBook": 5.42,
          "ProfitMargin": 0.25,
          "ReturnOnAssets": 0.0761,
          "ReturnOnEquity": 0.302,
          "DividendYield": 0.0287
        }
      },
      "kpis": {
        "Net Income": {
          "value": 4049000000,
          "growth": {
            "qoq": null,
            "yoy": null
          }
        },
        "Operating Margin %": 0.216,
        "Return on Equity (ROE)": 0.302,
        "Free Cash Flow": {
          "value": 6274000000,
          "growth": {
            "qoq": null,
            "yoy": null
          }
        },
        "FCF Margin": 0.293
      },
      "insights": {
        "profitability": "Johnson & Johnson reported a net income of $4,049,000,000 with an operating margin of 21.6%.",
        "financial_standing": "The company has total assets of $167,558,000,000 and total liabilities of $98,784,000,000, resulting in equity of $68,774,000,000.",
        "cash_flow": "Johnson & Johnson generated a free cash flow of $6,274,000,000.",
        "ratios": "The PE ratio stands at 18.91, with a profit margin of 25%."
      }
    },
    {
      "company_info": {
        "symbol": "PFE",
        "name": "Pfizer Inc.",
        "cik": null,
        "exchange": null,
        "sector": "Healthcare",
        "industry": null,
        "fiscal_year_end": null,
        "country": null,
        "market_cap": null
      },
      "annual": {
        "profitability": {
          "revenue": 14570000000,
          "gross_profit": 5980000000,
          "operating_income": -1263000000,
          "net_income": -3343000000
        },
        "balance_sheet": {
          "cash": 2853000000,
          "assets": 226501000000,
          "liabilities": 137213000000,
          "equity": 89014000000,
          "debt": 60982000000
        },
        "cash_flow": {
          "operating_cash_flow": 5240000000,
          "capex": 1044000000,
          "free_cash_flow": 4196000000,
          "earnings_quality": -1.57
        },
        "ratios": {
          "PE_Ratio": 13.3,
          "PEG_Ratio": 0.858,
          "PriceToBook": 1.611,
          "ProfitMargin": 0.168,
          "ReturnOnAssets": 0.0525,
          "ReturnOnEquity": 0.122,
          "DividendYield": 0.0677
        }
      },
      "kpis": {
        "Net Income": {
          "value": -3343000000,
          "growth": {
            "qoq": null,
            "yoy": null
          }
        },
        "Operating Margin %": -0.087,
        "Return on Equity (ROE)": 0.122,
        "Free Cash Flow": {
          "value": 4196000000,
          "growth": {
            "qoq": null,
            "yoy": null
          }
        },
        "FCF Margin": 0.288
      },
      "insights": {
        "profitability": "Pfizer Inc. reported a net loss of $3,343,000,000 with an operating margin of -8.7%.",
        "financial_standing": "The company has total assets of $226,501,000,000 and total liabilities of $137,213,000,000, resulting in equity of $89,014,000,000.",
        "cash_flow": "Pfizer Inc. generated a free cash flow of $4,196,000,000.",
        "ratios": "The PE ratio stands at 13.3, with a profit margin of 16.8%."
      }
    },
    {
      "company_info": {
        "symbol": "UNH",
        "name": "UnitedHealth Group Incorporated",
        "cik": null,
        "exchange": null,
        "sector": "Healthcare",
        "industry": null,
        "fiscal_year_end": null,
        "country": null,
        "market_cap": null
      },
      "annual": {
        "profitability": {
          "revenue": 94427000000,
          "gross_profit": 22002000000,
          "operating_income": 7689000000,
          "net_income": 5455000000
        },
        "balance_sheet": {
          "cash": 25427000000,
          "assets": 273720000000,
          "liabilities": 174801000000,
          "equity": 88756000000,
          "debt": 58263000000
        },
        "cash_flow": {
          "operating_cash_flow": -5193000000,
          "capex": 959000000,
          "free_cash_flow": -6152000000,
          "earnings_quality": -0.95
        },
        "ratios": {
          "PE_Ratio": 13.16,
          "PEG_Ratio": 1.241,
          "PriceToBook": 2.907,
          "ProfitMargin": 0.0504,
          "ReturnOnAssets": 0.0646,
          "ReturnOnEquity": 0.216,
          "DividendYield": 0.0313
        }
      },
      "kpis": {
        "Net Income": {
          "value": 5455000000,
          "growth": {
            "qoq": null,
            "yoy": null
          }
        },
        "Operating Margin %": 0.081,
        "Return on Equity (ROE)": 0.216,
        "Free Cash Flow": {
          "value": -6152000000,
          "growth": {
            "qoq": null,
            "yoy": null
          }
        },
        "FCF Margin": -0.065
      },
      "insights": {
        "profitability": "UnitedHealth Group Incorporated reported a net income of $5,455,000,000 with an operating margin of 8.1%.",
        "financial_standing": "The company has total assets of $273,720,000,000 and total liabilities of $174,801,000,000, resulting in equity of $88,756,000,000.",
        "cash_flow": "UnitedHealth Group Incorporated reported a negative free cash flow of $6,152,000,000.",
        "ratios": "The PE ratio stands at 13.16, with a profit margin of 5.04%."
      }
    }
  ],
  "sector_comparison": {
    "sector": "Healthcare",
    "rankings": {
      "ratios.ProfitMargin": [
        {
          "company": "ABT",
          "value": 0.324
        },
        {
          "company": "JNJ",
          "value": 0.25
        },
        {
          "company": "PFE",
          "value": 0.168
        },
        {
          "company": "UNH",
          "value": 0.0504
        },
        {
          "company": "CVS",
          "value": 0.0118
        }
      ],
      "balance_sheet.long_term_debt": [
        {
          "company": "ABT",
          "value": 13599000000
        },
        {
          "company": "JNJ",
          "value": 25881000000
        },
        {
          "company": "PFE",
          "value": 60982000000
        },
        {
          "company": "CVS",
          "value": 58638000000
        },
        {
          "company": "UNH",
          "value": 58263000000
        }
      ],
      "ratios.PE_Ratio": [
        {
          "company": "PFE",
          "value": 13.3
        },
        {
          "company": "CVS",
          "value": 19.11
        },
        {
          "company": "JNJ",
          "value": 18.91
        },
        {
          "company": "UNH",
          "value": 13.16
        },
        {
          "company": "ABT",
          "value": 16.53
        }
      ],
      "cash_flow.fcf_margin": [
        {
          "company": "PFE",
          "value": 0.288
        },
        {
          "company": "JNJ",
          "value": 0.293
        },
        {
          "company": "ABT",
          "value": 0.222
        },
        {
          "company": "CVS",
          "value": -0.038
        },
        {
          "company": "UNH",
          "value": -0.065
        }
      ]
    },
    "notes": "Rankings are ordered highest_to_lowest by metric value; ties retain input order; nulls are listed last."
  }
}